Related Experiment Video

Updated: May 15, 2026

VDJ-Seq: Deep Sequencing Analysis of Rearranged Immunoglobulin Heavy Chain Gene to Reveal Clonal Evolution Patterns of B Cell Lymphoma
15:07

VDJ-Seq: Deep Sequencing Analysis of Rearranged Immunoglobulin Heavy Chain Gene to Reveal Clonal Evolution Patterns of B Cell Lymphoma

Published on: December 28, 2015

Hierarchy in somatic mutations arising during genomic evolution and progression of follicular lymphoma

Michael R Green1, Andrew J Gentles, Ramesh V Nair

  • 1Division of Oncology, Department of Medicine, Stanford University, Stanford, CA 94305, USA.

Blood
|January 9, 2013
PubMed

Insights

Follicular lymphoma (FL) treatment requires new strategies due to its incurability. This study reveals significant genetic diversity within FL tumors, identifying early and late mutations crucial for developing targeted therapies.

Area of Science:

  • Oncology
  • Genetics
  • Molecular Biology

Background:

  • Follicular lymphoma (FL) remains incurable with current treatments, necessitating novel therapeutic approaches.
  • Targeting actionable somatic mutations is a promising strategy, but requires understanding their presence in tumor cell populations.
  • Intratumoral heterogeneity poses a challenge for mutation-directed therapies in FL.

Purpose of the Study:

  • To investigate the clonal diversity and hierarchy of genetic mutations within follicular lymphoma tumors.
  • To differentiate between early and late genetic events in lymphomagenesis.
  • To identify suitable genetic targets for novel follicular lymphoma therapies.

Main Methods:

  • Whole exome sequencing of follicular lymphoma tumor subpopulations.
  • Analysis of immunoglobulin somatic mutations and IGH-BCL2 translocations.
  • Comparison of genetic profiles from diagnosis and relapse tumor pairs.

Main Results:

  • Striking intratumoral clonal diversity was observed in follicular lymphoma, with mutations unevenly distributed across genes.
  • IGH-BCL2 translocations and CREBBP mutations were identified as early genetic events.
  • MLL2 and TNFRSF14 mutations were characterized as likely late genetic events in follicular lymphoma evolution.

Conclusions:

  • Follicular lymphoma tumors exhibit significant genetic heterogeneity, impacting the efficacy of targeted therapies.
  • Understanding the timing of genetic mutations is critical for selecting appropriate therapeutic targets.
  • This research provides insights into early and late genetic drivers, guiding the development of precision medicine for follicular lymphoma.

More Related Videos

Analysis of Somatic Hypermutation in the JH4 intron of Germinal Center B cells from Mouse Peyer's Patches09:35

Analysis of Somatic Hypermutation in the JH4 intron of Germinal Center B cells from Mouse Peyer's Patches

Published on: April 20, 2021

Wild-type Blocking PCR Combined with Sanger Sequencing for Detection of Low-frequency Somatic Mutation07:17

Wild-type Blocking PCR Combined with Sanger Sequencing for Detection of Low-frequency Somatic Mutation

Published on: August 23, 2024

Related Concept Videos

Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
Mutations01:39

Mutations

Overview
Mutations01:35

Mutations

Mutations are changes in the sequence of DNA. These changes can occur spontaneously or they can be induced by exposure to environmental factors. Mutations can be characterized in a number of different ways: whether and how they alter the amino acid sequence of the protein, whether they occur over a small or large area of DNA, and whether they occur in somatic cells or germline cells.
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Cells of the Adaptive Immune Response01:23

Cells of the Adaptive Immune Response

The T and B lymphocytes of the adaptive immune system develop from common lymphoid progenitor cells in the bone marrow. These progenitors give rise to precursors that eventually develop into both T and B lymphocytes. As these precursors mature, they gain the ability to detect and respond to foreign antigens in the body, a process known as immunocompetence. Additionally, these precursors acquire self-tolerance, a process that ensures they do not react to self-antigens. This intricate system...